Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 06, 2025
Ardena announced the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer. These appointments strengthen Ardena’s executive leadership team and reflect its continued focus on quality, compliance, and ...
read more
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
read more
Tuesday, February 04, 2025
Ardena announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey.
read more
Thursday, January 29, 2026
Ardena announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB.
read more
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life cycle, has announced upgrades to its development and manufacturing facilities in ...
read more
Tuesday, October 29, 2024
Ardena announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a brand new bioanalytical lab at Ardena’s Pivot Park facility in Oss, along with additional capacity and new ...
read more
Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.
read more
Monday, September 11, 2017
A new early-phase contract development and manufacturing organization, Ardena, has launched following the merging of Pharmavize and Crystallics.
read more
Ardena announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.
read more
Wednesday, November 29, 2023
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has been granted a Good Manufacturing Practice (GMP) license by the Belgian Federal Agency for Medicines and Health Products (...
read more
Tuesday, November 19, 2024
Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more
Tuesday, December 05, 2017
Arena Pharmaceuticals and Everest Medicines Limited have entered into a development and commercialization partnership for ralinepag and etrasimod in the Territories.
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, January 16, 2020
Argonaut Manufacturing Services has announced the recent launch of their state-of-the-art aseptic vial filling services.
read more